Gentherm Reports 2026 Third Quarter Results

Shareholders received a $63.5 million special cash dividend on October 7 as part of the Modine transaction.

Rhea-AI Summary

Gentherm (NASDAQ: THRM) reported third-quarter product revenue of $405.1 million, with sales growth accompanied by lower earnings and cash generation. Revenue rose 4.7% year over year, or 4.4% excluding currency translation. Net loss was $2.6 million, or $0.08 per diluted share, versus net income of $14.9 million, or $0.49 per share. Gross margin fell to 23.3% from 24.6%, while operating cash flow declined to $36.0 million from $87.8 million.

The Modine Performance Technologies combination closed October 1. Including its expected fourth-quarter contribution, Gentherm raised 2026 revenue guidance to $1.825–$1.925 billion, adjusted EBITDA guidance to $210–$230 million and adjusted free cash flow guidance to $100–$120 million. Automotive new business awards totaled $555 million in the quarter. Gentherm repurchased $60 million of stock after the combination, leaving approximately $340 million authorized.

19 points · 1 major

MixediHow this balance works

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

How the balance worksHow Sentiment works

0 major · 20 points

Hollow bars mark forward-looking points. How the balance works

Positive

• Major point. Forward-looking: it has not happened yet and may not happen.2026 revenue guidance increased to $1.825–$1.925 billion from $1.55–$1.65 billion, including expected Modine contribution.
• Moderate pointThird-quarter product revenue rose 4.7% to $405.1 million; growth excluding currency translation was 4.4%.
• Moderate pointModine Performance Technologies combination completed October 1.
• Moderate pointAutomotive new business awards totaled $555 million in the third quarter. 36% of market cap
• Moderate pointSpecial dividend returned $63.5 million, or $2.07 per share, on October 7.
• Moderate pointPost-combination stock repurchases totaled $60 million, leaving approximately $340 million under July’s up-to-$400 million authorization. 3.9% of market cap
• Moderate pointNine-month adjusted EBITDA increased to $143.134 million from $134.245 million.
• Moderate pointNine-month adjusted diluted earnings per share increased to $1.90 from $1.78.
• Moderate pointCash and equivalents increased to $252.098 million at September 30 from $160.833 million at December 31.
• Moderate pointQuarter-end liquidity totaled $494.2 million, with net leverage of approximately 0.4 times.

9 minor points

• Minor point. Forward-looking: it has not happened yet and may not happen.2026 adjusted EBITDA guidance increased to $210–$230 million from $185–$200 million.
• Minor point. Forward-looking: it has not happened yet and may not happen.2026 adjusted free cash flow guidance increased to $100–$120 million from $85–$100 million.
• Minor pointInnovative Medical Equipment acquisition completed July 1, adding the ThermaZone thermal therapy device.
• Minor pointClimate Control Seats revenue increased 7.1% to $215.603 million year over year in the third quarter.
• Minor pointLumbar and Massage Comfort Solutions revenue increased 27.1% to $70.923 million in the third quarter.
• Minor pointMedical segment revenue increased 14.6% to $14.505 million year over year in the third quarter.
• Minor pointClimate and Comfort growth excluding currency translation exceeded relevant-market vehicle production performance by 12 percentage points.
• Minor pointNine-month product revenue increased 8.9% to $1,214.974 million; growth excluding currency translation was 7.0%.
• Minor pointThird-quarter net research and development expenses declined to $23.465 million from $24.429 million.

Negative

• Moderate pointThird-quarter net results fell to a $2.6 million loss from $14.9 million income; diluted EPS fell to $(0.08).
• Moderate pointThird-quarter gross margin declined to 23.3% from 24.6%, reflecting currency, higher net material costs and inflation.
• Moderate pointThird-quarter operating cash flow declined to $36.0 million from $87.8 million.
• Moderate pointThird-quarter adjusted free cash flow declined to $59.5 million from $72.3 million.
• Moderate pointThird-quarter adjusted EBITDA declined to $45.0 million from $49.0 million; margin fell to 11.1% from 12.7%.
• Moderate pointThird-quarter adjusted diluted earnings per share declined to $0.33 from $0.73.
• Moderate pointLong-term debt excluding current maturities increased to $319.531 million from $189 million at December 31.

13 minor points

• Minor pointThird-quarter operating income declined to $14.363 million from $23.858 million.
• Minor pointThird-quarter income tax expense increased to $13.430 million from $5.935 million.
• Minor pointThird-quarter selling, general and administrative expenses increased to $51.638 million from $42.875 million.
• Minor pointThird-quarter restructuring expenses increased to $4.838 million from $3.986 million.
• Minor pointMerger and acquisition expenses totaled $6.528 million in the quarter and $34.187 million over nine months.
• Minor pointThird-quarter net interest expense increased to $3.832 million from $3.313 million.
• Minor pointClimate Control Interiors revenue declined 1.3% to $51.939 million year over year in the third quarter.
• Minor pointClimate and Comfort Electronics revenue declined 7.8% to $7.925 million in the third quarter.
• Minor pointValve Systems revenue declined 11.8% to $21.596 million year over year in the third quarter.
• Minor pointOther Automotive revenue declined 28.0% to $22.611 million year over year in the third quarter.
• Minor pointNine-month net income declined to $6.048 million from $15.298 million; diluted EPS fell to $0.19 from $0.50.
• Minor pointNine-month operating income declined to $36.337 million from $64.928 million.
• Minor pointNine-month adjusted EBITDA margin declined to 11.8% from 12.0%, despite higher adjusted EBITDA.

News Explained

The reported liquidity is a September 30 snapshot, before the October 7 dividend.

On October 7, Gentherm returned $63.5 million to shareholders as a special cash dividend of $2.07 per share, a completed cash payment.

At September 30, the company reported net leverage of about 0.4x and liquidity of $494.2 million; that snapshot predates the dividend.

Argus 15 min delay 2 alerts

-6.59% vs previous close $26.57 last price 26.3x rel. volume Open Argus

Details

Market move: THRM -6.59% vs previous close. 3Q26 earnings report

$26.00 – $28.58 Day Range

$1.45B Mkt Cap at Last Price

On Oct 22, the day this news came out, the latest delayed price for THRM is 6.59% below the previous close. Our momentum scanner has recorded 2 alerts for this stock so far that day. The latest delayed price is $26.57. Relative volume is exceptionally heavy at 26.3x the average.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.

Key Figures

Product revenues: $405.1 million, up 4.7% Gross margin: 23.3% Adjusted EBITDA: $45.0 million +5 more

Product revenues

$405.1 million, up 4.7%

3Q 2026 versus 3Q 2025

Gross margin

23.3%

3Q 2026; compared with 24.6% in 3Q 2025

Adjusted EBITDA

$45.0 million

3Q 2026; compared with $49.0 million in 3Q 2025

Adjusted diluted EPS

$0.33

3Q 2026; compared with $0.73 in 3Q 2025

2026 product revenue guidance

$1.825B–$1.925B

Updated October guidance; July range was $1.55B–$1.65B

2026 adjusted EBITDA guidance

$210M–$230M

Updated October guidance; July range was $185M–$200M

2026 adjusted free cash flow guidance

$100M–$120M

Updated October guidance; July range was $85M–$100M

Common stock repurchased

$60 million

Repurchased following the October combination

Historical Context

1 past event · Latest: Oct 01

1 event

1. Oct 01

   Combination completion

   24h Move

   -6.9%

   Gentherm completed the Modine combination; the earlier report specified ownership allocation and a $2.07 special dividend.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

adjusted ebitda, adjusted free cash flow, non-gaap financial measures, net leverage

4 terms

adjusted ebitda financial

"Adjusted EBITDA was $45.0 million, or 11.1% of revenue"

Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.

adjusted free cash flow financial

"Adjusted free cash flow was $59.5 million"

Adjusted free cash flow is the amount of money a company generates from its operations after accounting for essential expenses and investments, like maintaining or upgrading equipment. It shows how much cash is truly available to grow the business, pay debts, or return to shareholders, helping investors see the company's financial health more clearly.

non-gaap financial measures financial

"The Company provides various non-GAAP financial measures in this release."

Non-GAAP financial measures are numbers companies use to show their financial performance that exclude certain expenses or income. They help investors see how the company might perform without one-time costs or other unusual items, giving a different perspective from official reports. However, since they can be adjusted, they don’t always tell the full story and should be looked at alongside standard financial figures.

net leverage financial

"Third quarter ended with net leverage of ~0.4x"

Net leverage measures how many years it would take for a company to pay off its outstanding debt using its annual operating cash flow, after subtracting cash on hand from total debt. Think of it like a household’s mortgage balance minus savings divided by yearly income; a lower number means the company is in a safer position to handle debt, while a higher number signals greater financial risk and potential pressure on profits or growth.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Delivered Revenue of $405 Million, up 4.4% (ex-FX) Year-over-Year 

2026 Full Year Guidance Updated to Include Modine Performance Technologies

Repurchased $60 Million of Common Stock in October

NOVI, Mich., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), a global leader of innovative thermal and precision flow management technologies, today announced its financial results for the third quarter ended September 30, 2026.

“Our third quarter results were in line with expectations as we made continued progress on growth and operational excellence initiatives, while completing the Modine Performance Technologies combination on October 1,” said Bill Presley, the Company's President and CEO. “With the completion of the transaction, we are fundamentally a different company. We are entering an exciting new phase for Gentherm with industry leading platforms and I am increasingly confident in the significant value creation opportunities ahead.”

Third Quarter Highlights

• Secured Automotive New Business Awards totaling $555 million in the quarter.
• Expanded portfolio of differentiated technologies with launch of ThermAffyx™ Patient Safety System and Puls.A™.
• Product revenues of $405.1 million increased 4.7% from $386.9 million in the prior year. Excluding the impact of foreign currency translation, product revenues increased 4.4%.
• Automotive Climate and Comfort Solutions revenue increased 8.8% year over year, or 8.5% excluding the impact of foreign currency translation, outperforming S&P Global’s mid-October light vehicle production report in our relevant markets by 12 percentage points.
• Gross margin was 23.3%, compared to 24.6% in the prior year. The decrease was primarily driven by foreign exchange, higher net material costs and inflation, partially offset by strong operating leverage.
• Net (loss) income was $(2.6) million, compared to $14.9 million in the prior year.
• Adjusted EBITDA was $45.0 million, or 11.1% of revenue, compared to $49.0 million, or 12.7% of revenue, in the prior year.
• GAAP diluted (loss) earnings per share was $(0.08), compared to $0.49 in the prior year.
• Adjusted diluted earnings per share was $0.33, compared to $0.73 in the prior year.
• Cash flow from operations was $36.0 million, compared to $87.8 million in the prior year.
• Adjusted free cash flow was $59.5 million, compared to $72.3 million in the prior year.

The Company provides various non-GAAP financial measures in this release. See “Use of Non-GAAP Measures” below for additional information, including definitions, usefulness for investors and limitations, as well as reconciliations below to the most directly comparable GAAP financial measures.

Guidance

The Company updated its full year 2026 guidance to reflect the expected contribution from Modine Performance Technologies in the fourth quarter¹.

	As of July 2026	As of October 2026
Product Revenues	$1.55B – $1.65B	$1.825B – $1.925B
Adjusted EBITDA	$185M – $200M	$210M – $230M
Adjusted Free Cash Flow	$85M – $100M	$100M – $120M

¹2026 guidance based on tariffs currently in effect as of today, our current forecast of customer demand and expectations of near-term conditions, light vehicle production in our relevant markets decreasing at a low single digit rate for full year 2026 versus 2025, and a EUR to USD exchange rate of $1.15/Euro.

Capital Allocation Update

• On July 1, acquired Innovative Medical Equipment, LLC, provider of the ThermaZone® thermal therapy device, expanding thermal management product portfolio and providing strong cross-selling opportunities by leveraging complementary customer bases across additional healthcare channels.
• On October 1, completed combination with Modine’s Performance Technologies business.
• On October 7, returned $63.5 million to shareholders through a special cash dividend of $2.07 per share as part of the Modine transaction.
• In July, the Board of Directors authorized a new stock repurchase program of up to $400 million of the Company’s issued and outstanding common stock. Following the closing of the transaction with Modine in October, the Company repurchased $60 million of common stock. As of today, the program has approximately $340 million of stock repurchase authorization remaining.
• Third quarter ended with net leverage of ~0.4x and liquidity of $494.2 million.

“As expected, following the combination with Modine Performance Technologies, we remain in a strong financial position and continue to have confidence in the ability to generate significant cash moving forward,” said Jon Douyard, the Company’s Chief Financial Officer. “We believe the current share price does not reflect the value of the Company. We previously communicated our intention to repurchase shares following the Modine transaction. Since closing, we have repurchased $60 million and we remain committed to returning capital to shareholders, particularly in times of value dislocation.”

Conference Call

As previously announced, Gentherm will conduct a conference call today at 8:00 am Eastern Time to review these results. The dial-in number for the call is 1-877-407-4018 (callers in the U.S.) or +1-201-689-8471 (callers outside the U.S.). The passcode for the live call is 13763267.

A live webcast and one-year archived replay of the call, as well as a copy of the supplemental materials that will be used during the conference call, can be accessed on the Events page of the Investor section of Gentherm's website at www.gentherm.com.

A telephonic replay will be available approximately two hours after the call until 11:59 pm Eastern Time on November 5, 2026. The replay can be accessed by dialing 1-844-512-2921 (callers in the U.S.), or +1-412-317-6671 (callers outside the U.S.). The passcode for the replay is 13763267.

Investor Contact 
Gregory Blanchette
investors@gentherm.com
248.308.1702 

Media Contact 
Haley Baur 
media@gentherm.com
248.289.9711

About Gentherm
Gentherm (NASDAQ: THRM) is a global leader of innovative thermal and precision flow management technologies. The Company brings together industry leading products from Gentherm’s climate, comfort and valves businesses serving the light vehicle, medical, and home and office markets, with Modine’s highly engineered, mission-critical thermal solutions serving commercial vehicle, off-highway equipment, light vehicle and power generation markets. Gentherm has more than 18,000 employees in facilities across 17 countries. For more information, go to www.gentherm.com. 

Forward-Looking Statements 
Except for historical information contained herein, statements in this release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements represent Gentherm Incorporated's goals, beliefs, plans and expectations about its prospects for the future and other future events. The forward-looking statements included in this release are made as of the date hereof or as of the date specified herein and are based on management's reasonable expectations and beliefs. In making these statements we rely on assumptions and analysis based on our experience and perception of historical trends, current conditions and expected future developments, third party information and projections from sources that management believes to be reputable, as well as other factors we consider appropriate under the circumstances. Such statements are subject to a number of important assumptions, significant risks and uncertainties (some of which are beyond our control) and other factors that may cause actual results or performance to differ materially from that described in or indicated by the forward-looking statements, including but not limited to:

• macroeconomic, geopolitical and similar global factors in the cyclical Automotive industry;
• the impact of, and our ability to mitigate the effects of, global economic and trade policies, including increases in duties, tariffs and taxation on the import or export of our products related to U.S. trade disputes;
• increasing U.S. and global competition, including with non-traditional entrants;
• our ability to effectively manage new product launches and research and development, and the market acceptance of such products and technologies;
• the evolution and challenges of the automotive industry towards electric vehicles, autonomous vehicles and mobility on demand services, and related consumer behaviors and preferences;
• our ability to convert automotive new business awards into product revenues;
• the constraints in the supply chain environment, and inflationary and other cost pressures;
• the production levels of our major customers and OEMs in our relevant markets and sudden fluctuations in such production levels;
• our business in China, which is subject to unique operational, competitive, geopolitical, regulatory and economic risks;
• the impact of our global operations, including our cost structure and global manufacturing footprint, operations within Ukraine, and foreign currency and exchange risk;
• our product quality and safety and impact of product safety recalls and alleged defects in products;
• our ability to attract and retain highly skilled employees and wage inflation;
• a tightening labor market, labor shortages or work stoppages impacting us, our customers or our suppliers, such as recent labor strikes among certain OEMs and suppliers;
• our achievement of product cost reductions to offset customer-imposed price reductions or other pricing pressures;
• our ability to execute efforts to optimize our global supply chain and manufacturing footprint, including opening new facilities and transferring production;
• our ability to source, consummate, integrate and achieve planned benefits of strategic acquisitions, investments and, as applicable, exits;
• any security breaches and other disruptions to our information technology networks and systems, as well as privacy, data security and data protection risks, including risks associated with use of artificial intelligence capabilities in our business operations;
• any loss or insolvency of our key customers and OEMs, or key suppliers;
• our ability to project future sales volume based on third-party information, based on which we manage our business;
• the protection of our intellectual property in certain jurisdictions;
• our compliance with global anti-corruption laws and regulations;
• legal and regulatory proceedings and claims involving us or one of our major customers;
• the extensive regulation of our patient temperature management business;
• risks associated with our manufacturing processes;
• the effects of climate change and regulatory and stakeholder-imposed requirements to address climate change and other sustainability issues;
• our product quality and safety;
• our borrowing availability under our revolving credit facility, as well as the ability to access the capital markets, to support our planned growth; and
• our indebtedness and compliance with our debt covenants.

Furthermore, important factors related to the combination with Modine Performance Technologies (the “Transaction”) could cause actual results to differ materially from those currently anticipated, including:

• uncertainty of the expected financial performance of the combined company following completion of the Transaction;
• failure to realize the anticipated benefits of the Transaction;
• the ability of the combined company to implement its business strategy;
• difficulties and delays in the combined company achieving revenue and cost synergies;
• inability of the combined company to retain and hire key personnel;
• evolving legal, regulatory and tax regimes;
• changes in general economic and/or industry specific conditions or any volatility resulting from the imposition of and changing policies, including those policies with respect to tariffs; and
• actions by third parties, including government agencies.

The foregoing risks should be read in conjunction with the Company's reports filed with or furnished to the Securities and Exchange Commission (the “SEC”), including “Risk Factors,” in its most recent Annual Report on Form 10-K and subsequent SEC filings, for a discussion of these and other risks and uncertainties. In addition, with reasonable frequency, we have entered into business combinations, acquisitions, divestitures, strategic investments and other significant transactions. Such forward-looking statements do not include the potential impact of any such transactions that may be completed after the date hereof, each of which may present material risks to the Company’s future business and financial results. Moreover, we operate in a very competitive and rapidly changing environment and new risks emerge from time to time.

Except as required by law, the Company expressly disclaims any obligation or undertaking to update any forward-looking statements to reflect any change in its strategies or expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. 

Use of Non-GAAP Financial Measures
In addition to the results reported in accordance with GAAP throughout this release, the Company has provided here or elsewhere information regarding: adjusted earnings before interest, taxes, depreciation and amortization (“Adjusted EBITDA”); Adjusted EBITDA margin; Adjusted net income; Adjusted earnings per share (“Adjusted earnings per share” or “Adjusted EPS”); Quarter-to-date Operating Cash Flow; Free Cash Flow; Adjusted Free Cash Flow; Adjusted Free Cash Flow Conversion rate; net capital expenditures (“net CAPEX”); Net Debt; Liquidity; Net Leverage Ratio (“Net Leverage”); revenue, segment revenue and product revenue excluding foreign currency translation and other specified gains and losses; Adjusted operating expenses; Pro Forma Revenue; Pro Forma Adjusted EBITDA; and Pro Forma Adjusted EBITDA Margin, each a non-GAAP financial measure. The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, deferred financing cost amortization, non-cash stock based compensation expenses, restructuring expenses, net, unrealized currency gain or loss and other gains and losses not reflective of the Company’s ongoing operations and related tax effects. The Company defines Adjusted EBITDA margin as Adjusted EBITDA divided by product revenues. The Company defines Adjusted net income as earnings adjusted by restructuring expenses, net, unrealized currency gain or loss and other gains and losses not reflective of the Company’s ongoing operations and related tax effects. The Company defines Adjusted EPS as Adjusted net income divided by the Company’s weighted average shares outstanding. The Company defines Quarter-to-date Operating Cash Flow as Net cash provided by/(used in) operating activities for the current period, less that of the immediately preceding period. The Company defines Free Cash Flow as Net cash provided by/(used in) operating activities plus Proceeds from the sale of property and equipment less Purchases of property and equipment. The Company defines net CAPEX as Purchases of property and equipment less Proceeds from the sale of property and equipment. The Company defines Adjusted Free Cash Flow as Net cash provided by/(used in) operating activities, excluding cash restructuring expenses, net and other gains and losses not reflective of the Company’s ongoing operations, less net CAPEX. The Company defines Adjusted Free Cash Flow Conversion rate as Adjusted Free Cash Flow divided by Adjusted EBITDA. The Company defines Net Debt as the principal amount of all Consolidated Funded Indebtedness (as defined in the Credit Agreement) less cash and cash equivalents. The Company defines Liquidity as the sum of cash and cash equivalents and availability under the Company’s revolving line of credit. The Company defines Net Leverage as Net Debt divided by Adjusted EBITDA for the trailing four fiscal quarters. The Company defines revenue, segment revenue or product revenue excluding foreign currency translation and other specified gains and losses as such revenue, excluding the estimated effects of foreign currency exchange on revenue by translating actual revenue using the prior period foreign currency exchange rates and excluding the other items specified. The Company defines Adjusted operating expenses as operating expenses excluding related non-cash stock based compensation, restructuring expenses, net, and other gains and losses not reflective of the Company’s ongoing operations. The Company defines Pro Forma Revenue as Gentherm’s product revenues for the trailing four fiscal quarters (from the date specified), plus Modine Performance Technologies’ Net sales for the trailing four fiscal quarters (from the date specified), as reported by Modine Manufacturing Company, adjusted to reflect the latest business structure. The Company defines Pro Forma Adjusted EBITDA as Gentherm’s Adjusted EBITDA for the trailing four fiscal quarters (from the date specified), plus Modine Performance Technologies’ Adjusted EBITDA for the trailing four fiscal quarters (from the date specified), as reported by Modine Manufacturing Company, adjusted to reflect the latest business structure and go-forward operational alignment. The Company defines Pro Forma Adjusted EBITDA Margin as Pro Forma Adjusted EBITDA divided by Pro Forma Revenue.

The Company’s reconciliations are included in this release or can be found in the supplemental materials for this reporting period on the Company’s website.

In evaluating its business, the Company considers and uses Quarter-to-date Operating Cash Flow, Free Cash Flow, Adjusted Free Cash Flow, Adjusted Free Cash Flow Conversion rate, Net Debt, Net Leverage and Liquidity as supplemental measures of its liquidity and the other non-GAAP financial measures as supplemental measures of its operating performance. Management provides such non-GAAP financial measures so that investors will have the same financial information that management uses with the belief that it will assist investors in properly assessing the Company's performance on a period-over-period basis by excluding matters not indicative of the Company’s ongoing operating or liquidity results and therefore enhance the comparability of the Company's results and provide additional information for analyzing trends in the business. In evaluating our non-GAAP financial measures, you should be aware that in the future we may incur revenues, expenses, and cash and non-cash obligations that are the same as or similar to some of the adjustments in our presentation of non-GAAP financial measures. Our presentation of non-GAAP financial measures should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items. There also can be no assurance that we will not modify the presentation of our non-GAAP financial measures in the future, and any such modification may be material. Other companies in our industry may define and calculate these non-GAAP financial measures differently than we do and those calculations may not be comparable to our metrics. These non-GAAP measures have limitations as analytical tools, and when assessing the Company's operating performance or liquidity, investors should not consider these non-GAAP measures in isolation, or as a substitute for net income/(loss), revenue or other consolidated income/(loss) statement or cash flow statement data prepared in accordance with GAAP.

Non-GAAP measures referenced in this release and other public communications may include estimates of future Adjusted EBITDA, Adjusted EBITDA margin, Adjusted Free Cash Flow, Adjusted Free Cash Flow Conversion rate, Adjusted EPS, Pro Forma Revenue, Pro Forma Adjusted EBITDA and Pro Forma Adjusted EBITDA Margin. The Company has not reconciled the non-GAAP forward-looking guidance included in this release to the most directly comparable GAAP measures because this cannot be done without unreasonable effort due to the variability and low visibility with respect to taxes and non-recurring items, which are potential adjustments to future earnings. We expect the variability of these items to have a potentially unpredictable, and a potentially significant, impact on our future GAAP financial results.

GENTHERM INCORPORATED CONSOLIDATED CONDENSED STATEMENTS OF (LOSS) INCOME (Dollars in thousands, except per share data) (Unaudited)
		Three Months Ended September 30,								Nine Months Ended September 30,
		2026				2025				2026				2025
Product revenues		$	405,102			$	386,870			$	1,214,974			$	1,115,814
Cost of sales			310,798				291,722				927,016				844,439
Gross margin			94,304				95,148				287,958				271,375
Operating expenses:
Net research and development expenses			23,465				24,429				71,480				71,203
Selling, general and administrative expenses			51,638				42,875				162,648				122,440
Restructuring expenses, net			4,838				3,986				17,493				10,608
Loss on sale of land and building, net			—				—				—				2,196
Total operating expenses			79,941				71,290				251,621				206,447
Operating income			14,363				23,858				36,337				64,928
Interest expense, net			(3,832	)			(3,313	)			(9,755	)			(10,911	)
Foreign currency gain (loss)			193				339				(1,104	)			(27,391	)
Other income (loss)			116				—				300				(1,124	)
Earnings before income tax			10,840				20,884				25,778				25,502
Income tax expense			13,430				5,935				19,730				10,204
Net (loss) income		$	(2,590	)		$	14,949			$	6,048			$	15,298
Basic (loss) earnings per share		$	(0.08	)		$	0.49			$	0.20			$	0.50
Diluted (loss) earnings per share		$	(0.08	)		$	0.49			$	0.19			$	0.50
Weighted average number of shares – basic			30,672				30,480				30,613				30,619
Weighted average number of shares – diluted			30,672				30,748				31,078				30,802

GENTHERM INCORPORATED REVENUE BY PRODUCT CATEGORY AND RECONCILIATION OF FOREIGN CURRENCY TRANSLATION IMPACT (Dollars in thousands) (Unaudited)
		Three Months Ended September 30,												Nine Months Ended September 30,
		2026				2025				% Change				2026				2025				% Change
Climate Control Seats		$	215,603			$	201,275				7.1	%		$	639,656			$	592,448				8.0	%
Lumbar and Massage Comfort Solutions			70,923				55,799				27.1	%			205,772				153,642				33.9	%
Climate Control Interiors			51,939				52,638				(1.3	)%			155,241				147,564				5.2	%
Climate and Comfort Electronics			7,925				8,599				(7.8	)%			25,831				22,220				16.3	%
Automotive Climate and Comfort Solutions			346,390				318,311				8.8	%			1,026,500				915,874				12.1	%
Valve Systems			21,596				24,487				(11.8	)%			73,271				72,803				0.6	%
Other Automotive			22,611				31,413				(28.0	)%			77,807				91,260				(14.7	)%
Subtotal Automotive segment			390,597				374,211				4.4	%			1,177,578				1,079,937				9.0	%
Medical segment			14,505				12,659				14.6	%			37,396				35,877				4.2	%
Total Company		$	405,102			$	386,870				4.7	%		$	1,214,974			$	1,115,814				8.9	%
Foreign currency translation impact(a)			1,025				—								20,617				—
Total Company, excluding foreign currency translation impact		$	404,077			$	386,870				4.4	%		$	1,194,357			$	1,115,814				7.0	%
(a) Foreign currency translation impacts for the Automotive segment and Medical segment were $967 and $58 respectively, for the three months ended September 30, 2026. Foreign currency translation impacts for Automotive Climate and Comfort Solutions was $1,102 for the three months ended September 30, 2026. Foreign currency translation impacts for the Automotive segment and Medical segment were $20,107 and $510 respectively, for the nine months ended September 30, 2026. Foreign currency translation impacts for Automotive Climate and Comfort Solutions was $16,320 for the nine months ended September 30, 2026.

GENTHERM INCORPORATED RECONCILIATION OF NET (LOSS) INCOME TO ADJUSTED EBITDA AND ADJUSTED EBITDA MARGIN (Dollars in thousands) (Unaudited)
		Three Months Ended September 30,								Nine Months Ended September 30,
		2026				2025				2026				2025
Net (loss) income		$	(2,590	)		$	14,949			$	6,048			$	15,298
Add back:
Depreciation and amortization			14,704				13,274				43,087				39,120
Income tax expense			13,430				5,935				19,730				10,204
Interest expense, net			3,832				3,313				9,755				10,911
Adjustments:
Non-cash stock based compensation			2,925				3,980				10,371				10,569
Restructuring expenses, net			4,838				3,986				17,493				10,608
Unrealized currency loss			681				1,865				855				30,349
Merger and acquisition expenses			6,528				—				34,187				—
Leadership transition expenses			328				777				1,738				2,935
Loss on sale of land and building, net			—				—				—				2,196
Other(a)			328				928				(130	)			2,055
Adjusted EBITDA		$	45,004			$	49,007			$	143,134			$	134,245
Product revenues		$	405,102			$	386,870			$	1,214,974			$	1,115,814
Net (loss) income margin			(0.6	)%			3.9	%			0.5	%			1.4	%
Adjusted EBITDA margin			11.1	%			12.7	%			11.8	%			12.0	%
(a) Includes a $1,294 decrease in fair value of an equity investment for the nine months ended September 30, 2025.

GENTHERM INCORPORATED RECONCILIATION OF NET (LOSS) INCOME TO ADJUSTED NET INCOME AND ADJUSTED EARNINGS PER SHARE (Dollars in thousands, except per share data) (Unaudited)
		Three Months Ended September 30,								Nine Months Ended September 30,
		2026				2025				2026				2025
Net (loss) income		$	(2,590	)		$	14,949			$	6,048			$	15,298
Amortization of acquisition related intangibles			2,427				1,676				5,802				4,873
Restructuring expenses, net			4,838				3,986				17,493				10,608
Unrealized currency loss			681				1,865				855				30,349
Merger and acquisition expenses			6,528				—				34,187				—
Leadership transition expenses			328				777				1,738				2,935
Loss on sale of land and building, net			—				—				—				2,196
Other			(116	)			928				(574	)			2,055
Tax effect of above			(2,089	)			(1,582	)			(6,550	)			(13,422	)
Adjusted net income		$	10,007			$	22,599			$	58,999			$	54,892
Weighted average shares outstanding:
Basic			30,672				30,480				30,613				30,619
Diluted			30,672				30,748				31,078				30,802
(Loss) Earnings per share, as reported:
Basic		$	(0.08	)		$	0.49			$	0.20			$	0.50
Diluted		$	(0.08	)		$	0.49			$	0.19			$	0.50
Adjusted earnings per share:
Basic		$	0.33			$	0.74			$	1.93			$	1.79
Diluted		$	0.33			$	0.73			$	1.90			$	1.78

GENTHERM INCORPORATED CONSOLIDATED CONDENSED BALANCE SHEETS (Dollars in thousands, except share data) (Unaudited)
		September 30, 2026				December 31, 2025
ASSETS
Current Assets:
Cash and cash equivalents		$	252,098			$	160,833
Accounts receivable, net			326,217				281,083
Inventory:
Raw materials			127,403				128,314
Work in process			44,437				35,429
Finished goods			91,647				88,959
Inventory, net			263,487				252,702
Other current assets			85,678				82,332
Total current assets			927,480				776,950
Property and equipment, net			263,561				270,614
Goodwill			122,258				108,918
Other intangible assets, net			63,858				52,796
Operating lease right-of-use assets			48,674				56,524
Deferred income tax assets			93,853				93,552
Other non-current assets			42,615				37,075
Total assets		$	1,562,299			$	1,396,429
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current Liabilities:
Accounts payable		$	298,183			$	260,487
Current lease liabilities			7,846				9,646
Current maturities of long-term debt			912				73
Other current liabilities			144,999				134,104
Total current liabilities			451,940				404,310
Long-term debt, less current maturities			319,531				189,000
Non-current lease liabilities			42,469				48,105
Pension benefit obligation			3,281				3,748
Other non-current liabilities			23,760				30,943
Total liabilities		$	840,981			$	676,106
Shareholders’ Equity:
Common Stock:
No par value; 110,000,000 shares authorized 30,710,902 and 30,526,231 issued and outstanding at September 30, 2026 and December 31, 2025, respectively			13,442				5,611
Paid-in capital			1,590				1,590
Accumulated other comprehensive loss			(13,848	)			(964	)
Accumulated earnings			720,134				714,086
Total shareholders’ equity			721,318				720,323
Total liabilities and shareholders’ equity		$	1,562,299			$	1,396,429

GENTHERM INCORPORATED CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (Dollars in thousands) (Unaudited)
		Nine Months Ended September 30,
		2026				2025
Operating Activities:
Net income		$	6,048			$	15,298
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization			44,201				39,478
Deferred income taxes			(9,548	)			(12,836	)
Stock based compensation			10,371				10,573
Loss on disposition of property and equipment			121				2,671
Provisions for inventory			4,086				5,234
Other non-cash items, including unrealized foreign currency (gain) loss			(1,018	)			30,957
Changes in assets and liabilities:
Accounts receivable, net			(43,474	)			(20,543	)
Inventory			(22,133	)			(20,136	)
Other assets			(1,403	)			(22,325	)
Accounts payable			43,305				33,514
Other liabilities			5,451				25,935
Net cash provided by operating activities			36,007				87,820
Investing Activities:
Purchases of property and equipment			(22,558	)			(33,378	)
Proceeds from the sale of property and equipment			83				3,770
Acquisition of business, net of cash acquired			(34,152	)			—
Cost of technology investments			(121	)			(915	)
Proceeds from deferred purchase price of factored receivables			—				744
Net cash used in investing activities			(56,748	)			(29,779	)
Financing Activities:			—				—
Borrowings on debt			204,000				72,000
Repayments of debt			(85,887	)			(103,112	)
Cash paid for financing new loans			(2,761	)			—
Taxes withheld and paid on employees' stock based compensation			(2,540	)			(1,306	)
Cash paid for the repurchase of Common Stock			—				(10,015	)
Net cash provided by (used in) financing activities			112,812				(42,433	)
Foreign currency effect			(806	)			4,508
Net increase in cash and cash equivalents			91,265				20,116
Cash and cash equivalents at beginning of period			160,833				134,134
Cash and cash equivalents at end of period		$	252,098			$	154,250

GENTHERM INCORPORATED OTHER NON-GAAP RECONCILIATIONS (Dollars in thousands) (Unaudited)
		Three Months Ended September 30,								Nine Months Ended September 30,
		2026				2025				2026				2025
Total operating expenses		$	79,941			$	71,290			$	251,621			$	206,447
Restructuring expense, net			(4,838	)			(3,986	)			(17,493	)			(10,608	)
Non-cash stock based compensation			(2,889	)			(3,979	)			(9,843	)			(10,211	)
Merger and acquisition expenses			(6,528	)			—				(34,187	)			—
Leadership transition expenses			(328	)			(777	)			(1,738	)			(2,935	)
Loss on sale of land and building, net			—				—				—				(2,196	)
Other			—				(927	)			—				(927	)
Adjusted operating expenses		$	65,358			$	61,621			$	188,360			$	179,570

		September 30, 2026				September 30, 2025
Cash and cash equivalents		$	252,098			$	154,250
Revolving line of credit availability			242,141				307,938
Total liquidity		$	494,239			$	462,188

									September 30, 2026								September 30, 2025
Current maturities of long-term debt									$	912							$	109
Long-term debt, less current maturities										319,531								189,000
Total Debt										320,443								189,109
Cash and cash equivalents										252,098								154,250
Net Debt									$	68,345							$	34,859
Adjusted EBITDA for the trailing four fiscal quarters									$	181,034							$	175,620
Net Leverage										0.4								0.2

		Three Months Ended September 30,								Nine Months Ended September 30,
		2026				2025				2026				2025
Net cash provided by operating activities		$	33,735			$	56,119			$	36,007			$	87,820
Purchases of property and equipment			(8,355	)			(9,650	)			(22,558	)			(33,378	)
Proceeds from the sale of property and equipment			13				25				83				3,770
Free Cash Flow			25,393				46,494				13,532				58,212
Cash effect of adjustments:
Restructuring expenses, net			5,352				2,308				11,970				6,648
Merger and acquisition expenses			11,915				15				32,967				15
Leadership transition expenses			989				650				1,015				6,711
Other			—				2,103				—				704
Adjusted Free Cash Flow		$	43,649			$	51,570			$	59,484			$	72,290

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What were Gentherm’s third-quarter 2026 revenue and earnings?

Gentherm reported $405.1 million in revenue and a $2.6 million net loss for the quarter ended September 30, 2026. Revenue increased 4.7% year over year. Diluted loss per share was $0.08, compared with diluted earnings per share of $0.49 a year earlier.

What is Gentherm’s updated 2026 guidance after the Modine combination?

Gentherm expects $1.825–$1.925 billion in revenue, $210–$230 million in adjusted EBITDA and $100–$120 million in adjusted free cash flow for 2026. The updated outlook includes the expected fourth-quarter contribution from Modine Performance Technologies following the October 1 combination.

What assumptions underpin Gentherm’s updated 2026 guidance?

Gentherm bases its guidance on tariffs in effect on October 22, 2026, its customer-demand forecast and expectations for near-term conditions. It assumes relevant-market light vehicle production decreases at a low single digit rate versus 2025 and a euro-to-dollar exchange rate of $1.15 per euro.